Heart failure & cardiomyopathies

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

J Am Coll CardiolPublished Retrospective cohort study

Authors' conclusion

A significant percentage of patients with HFrEF experience improvement in ejection fraction, transitioning to HFimpEF, yet remain at significant clinical risk.

Study context

Population
Patients with incident Heart Failure with Reduced Ejection Fraction (HFrEF), Kaiser Permanente Northern California, January 2013–December 2022
Participants
28,292 patients
Exposure
Heart failure with improved ejection fraction (HFimpEF) vs persistent HFrEF
  • HFimpEFn = 8,656
Outcome
Worsening HF and death
Methodological detailsmultisite integrated health care delivery system
  • Multisite integrated health care delivery system

Main finding

As reported in the abstract

HFimpEF

Worsening HF
17.4 per 100 person-years (95% CI: 16.9-18.0)
Death
5.7 per 100 person-years (95% CI: 5.4-6.0)

Persistent HFrEF

Worsening HF
34.1 per 100 person-years (95% CI: 33.5-34.6)
Death
11.0 per 100 person-years (95% CI: 10.7-11.3)

Worsening HF

HFimpEF17.4 per 100 person-years (95% CI: 16.9-18.0)
Persistent HFrEF34.1 per 100 person-years (95% CI: 33.5-34.6)

Death

HFimpEF5.7 per 100 person-years (95% CI: 5.4-6.0)
Persistent HFrEF11.0 per 100 person-years (95% CI: 10.7-11.3)
HFimpEF vs Persistent HFrEFHazard ratio (95% CI)
Worsening HF
0.58(0.55–0.61)
Death
0.52(0.49–0.56)

Observational data: associations, not effects.

Further findings

Incidence of HFimpEF within 12 months
30.6% · 8,656

Guideline-directed medical therapy (GDMT) use after incident HFimpEF

Use of GDMT marginally decreased in most medication categories after incident HFimpEF

GDMT withdrawal

Withdrawal of GDMT modestly associated with greater clinical risk

Original publication

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction. J Am Coll Cardiol. Published 5 August 2025. doi:10.1016/j.jacc.2025.05.040

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.